Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lovastatin in HAART-naive HIV-1 infected individuals
NCT00721305Phase 2Completed
- Sponsor
- Universidad de Antioquia
- Start
- Aug 2008
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in human immunodeficiency virus type 1 infection (HIV-1) comparing Lovastatin with Placebo (2 arms). Primary endpoints: HIV-1 viral load at 12 months and CD4 T-cell count at 12 months. Started Aug 2008; status: completed.
02
Drugs
lovastatin
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00721305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00721305.